cholangiocellular

cholangiocellular

/cho·lan·gi·o·cel·lu·lar/ (-sel´u-lar) of, resembling, or pertaining to cells of the cholangioles.

cholangiocellular

pertaining to the bile ducts.

cholangiocellular adenoma
solid or cystic; may be neoplastic or congenital or acquired cystic lesions.
cholangiocellular carcinoma
multiple, firm, white tumors occurring usually in dogs and cats. Capsular lesions have a typical umbilication of their serosal surface. Metastatic spread is constant. Called also bile duct carcinoma.
cholangiocellular cystadenoma
a variety of bile duct adenoma in which the tumor is composed of multilocular cystic structures lined with epithelium resembling that of bile ducts.
References in periodicals archive ?
ALR is dysregulated in a number of solid tumors such as hepatocellular carcinoma, cholangiocellular carcinoma (15), and colorectal cancer (9).
Exclusion criteria were (1) mixed HCC or cholangiocellular carcinoma, (2) emergence of extrahepatic metastasis, (3) no R0 resection, (4) existence of another type of primary tumor, and (5) ever received chemotherapy, radiation therapy, or TACE before the surgery.
1995) and foci of cellular alteration, cortical tubular cysts lesions (renal system) (NTP, 2011) Chemical Level 4 * DEHP Hepatocarcinoma, cholan-giocellular tumors in male rats (standard bioassay male rats and PPARa-null mice), cholangiocellular carcinoma (PPARa-null mice), hepatocarcinoma in female rats (standard bioassay), increased incidence of kidney tumors in rats (ini-tiation/promotion protocol) (Garvey et al.
It can arise at the hepatocellular level because of impairment of bile secretion by hepatocytes or at cholangiocellular level, generally by obstruction of bile flow through intra- or extrahepatic bile ducts by gall stones or local malignancies [1].
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma," International Journal of Oncology, vol.
f) For liver tumors, updated classification used by QA and PWG pathologists and newer RI studies use hepatocellular adenoma/carcinoma descriptors, with those consisting of hepatocellular and cholangiocellular elements now being diagnosed as hepatocholangiomas or hepatocholangiocarcinomas.
Thus, we will consider benign liver tumors of epithelial and nonepithelial origin, with the epithelial tumors further classified into tumors of either cholangiocellular or hepatocellular origin.
Dysplasia of the biliary epithelium generated by bile stasis and chronic inflammation can develop a malignant transformation to cholangiocellular carcinoma in 5% to 14% of patients with CD.
7%) (poorly differ-entiated adenocarcinoma in two cases, moderately differentiated adenocarcinoma in three cases, and well differentiated adenocarcinoma in one case) (Fig-3A), cholangiocellular carcinoma in one case (11.
Vitamin K2-induced cell growth inhibition via autophagy formation in cholangiocellular carcinoma cell lines.
Transforming growth factor [beta]1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.